Galena Biopharma to Present at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference

LAKE OSWEGO, Ore., Sept. 27, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Rosemary Mazanet, M.D., Ph.D., Executive Vice President and Chief Medical Officer, will present a corporate overview at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference. The presentation will take place on Thursday, October 4, 2012 at 9:00 a.m. EDT at the New York Academy of Medicine in New York, NY.